Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B
NCT01595685
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
98
Enrollment
OTHER
Sponsor class
Conditions
Chronic Viral Hepatitis B Without Delta-agent
Interventions
DRUG:
Telbivudine
DRUG:
Entecavir
Sponsor
Asan Medical Center